https://www.mdanderson.org/newsroom/research-newsroom/phase-ii-study-identifies-potential-biomarkers-in-hpv-positive-anal-cancer.h00-159774867.html
Phase II study identifies potential biomarkers in HPV-positive anal cancer | UT MD Anderson
Phase II study identifies potential biomarkers in HPV-positive anal cancer
phase ii study
https://www.michaeljfox.org/grant/phase-ii-study-isradipine-disease-modifying-agent-early-parkinsons-disease?grant_id=486
Phase II Study of Isradipine as a Disease-modifying Agent in Early Parkinson's Disease |...
Objective/Rationale: Isradipine, a drug approved by the FDA for treatment of high blood pressure, has been found to be neuroprotective in pre-clinical models...
phase ii study
https://investingnews.com/cardiol-therapeutics-announces-completion-of-the-maveric-phase-ii-study-in-recurrent-pericarditis-with-results-to-be-presented-at-the-american-heart-association-scientific-sessions-2024/
Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis...
Sep 10, 2024 - Full clinical data will be reported in an oral presentation at the premier global event for advancements in cardiovascular science and medicine on November 18,...
phase ii study
https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2021-0585.html
Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the...
This is a Phase 2, single center, open-label, single-arm study designed to evaluate the efficacy, safety, tolerability, and immunogenicity of AK104 monotherapy...
phase ii study
https://www.mountsinai.org/about/newsroom/2019/asco-2019-randomized-doubleblind-phase-ii-study-of-maintenance-pembrolizumab-versus-placebo-after-firstline-chemotherapy-in-patients-with-metastatic-urothelial-cancer-hcrn-gu14182
"ASCO 2019: Randomized Double-blind Phase II Study of Maintenance Pembrolizumab Versus Placebo...
phase ii study
https://pmc.ncbi.nlm.nih.gov/articles/PMC11763628/
Phase II Study of Nanoliposomal Irinotecan (Nal-IRI) with 5-Fluorouracil and Leucovorin in...
This Phase 2 trial investigated the combination of nanoliposomal irinotecan (Nal-IRI), 5-fluorouracil (5-FU), and leucovorin (LV) in patients with advanced,...
phase ii study
https://www.dana-farber.org/clinical-trials/22-225
ETHAN: A phase II study comparing different Endocrine THerapies for mAle breast caNcer |...
This research study is looking to see how well male breast cancer responds to preoperative treatment with endocrine therapy and which endocrine therapy regimen...
phase ii study
https://www.biospace.com/cytokine-pharmasciences-completes-phase-ii-study-of-controlled-release-misoprostol-vaginal-insert-mvi
Cytokine PharmaSciences Completes Phase II Study of Controlled Release Misoprostol Vaginal Insert...
phase ii study
https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.IDNCI9673.html
NCI9673: Part A: A Multi-Institutional Phase II Study of Nivolumab in Refractory Metastatic...
This phase II trial studies how well nivolumab with or without ipilimumab works in treating patients with anal canal cancer that has not responded to previous...
phase ii study
https://www.mskcc.org/cancer-care/clinical-trials/20-091
A Phase II Study of Pembrolizumab Immunotherapy, Olaparib, and Temozolomide in People with...
Full Title A Phase II Study of Pembrolizumab, Olaparib, and Temozolomide in Patients with Glioma Purpose The purpose of this study is to assess the safety and...
phase ii study
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2017.00031/full
Frontiers | Commentary: Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in...
We read with great interest the report by Fayette et al summarizing the results of a phase II study of duligotuzumab (MEHD7945A) versus cetuximab in SCCHN an...
phase ii study
https://investingnews.com/cardiol-therapeutics-completes-patient-enrollment-in-its-phase-ii-maveric-pilot-study-investigating-cardiolrx-for-recurrent-pericarditis/
Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating...
Feb 21, 2024 - Topline Results Expected in Q2 2024This is a Designated News Release.Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...
https://www.mskcc.org/cancer-care/clinical-trials/20-011
A Phase II Study of Osimertinib Alone or with Chemotherapy for Patients with Metastatic EGFR-Mutant...
Full Title A Phase 2 Randomized Study of Osimertinib Versus Osimertinib Plus Chemotherapy for Patients with Metastatic EGFR-Mutant Lung Cancers That Have...
https://www.businesswire.com/news/home/20221024005568/en/Inotrem-Announces-That-Its-ESSENTIAL-Phase-II-Study-for-the-Treatment-of-Critically-ill-COVID-19-Patients-Meets-Its-Primary-and-Key-Secondary-Endpoints
Inotrem Announces That Its ESSENTIAL Phase II Study for the Treatment of Critically ill COVID-19...
Inotrem's ESSENTIAL Phase II study for the treatment of critically ill COVID-19 patients meets primary and key secondary endpoints.
https://www.biospace.com/quark-pharmaceuticals-inc-reports-positive-results-from-a-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-qpi-1002-for-the-prevention-of-acute
Quark Pharmaceuticals Inc. Reports Positive Results From A Phase II Study To Evaluate The Efficacy...
https://www.prnewswire.com/news-releases/data-safety-monitoring-board-recommends-completion-of-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-arakoda-tafenoquine-for-treatment-of-mild-moderate-covid-19-disease-301398568.html
Data Safety Monitoring Board Recommends Completion of Phase II Study to Evaluate the Efficacy and...
/PRNewswire/ -- 60 Degrees Pharmaceuticals, LLC (60P), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today...
data safety monitoring board